All results / Stories / Amy Stulick


IT Service Seeks Impact on Clients

Stephen Yeoh left corporate job to work with small businesses.

Stephen Yeoh decided to start IT company Un1teee in 2009 after working for a variety of large companies including Amgen Inc. in Thousand Oaks.

Post-Pandemic Hospitals

From the waiting room to virtual visits, the pandemic has altered the health care industry’s future trajectory.

How the pandemic has altered the health care industry’s future trajectory.

Tease photo

Doctor Charged With Medicare Fraud

A Porter Ranch physician was indicted Thursday on charges related to an alleged $6 million Medicare fraud scheme, according to the Justice Department.

Amgen’s Otezla May Be Approved for Broader Use

Amgen Inc. on Wednesday said its psoriasis drug Otezla was approved for review by the Food and Drug Administration to be used on a wider patient population.

Bank of Santa Clarita Acquired

Southern California Bancorp announced Tuesday it will acquire Bank of Santa Clarita for $56.2 million, the San Diego business said.

MannKind Reduces Debt by Nearly $50 Million

MannKind Corp. has reduced its debt by $49.5 million through a paid note to the Mann Group and an amended agreement with MidCap Financial Trust, the Westlake Village company said on Monday.

Deadline: June 15

RETAIL: Employment, hygiene and technology play roles in restaurants’ return to full service.

Eateries such as Maria’s Italian Kitchen prepare for full opening on June 15.

Cal Lutheran Looks at the Future of Telehealth

Corporate Leaders event spotlights experts from UCLA Health, Los Robles.

California Lutheran University looks at the future of telehealth.

Breakthrough Drug, Cancer Program at Amgen

Stomach treatment, lung diagnosis move ahead at pharma industry giant.

April was a busy month for Thousand Oaks biotech giant Amgen Inc., with its gastroesophageal cancer drug gaining breakthrough designation status with the U.S. Food and Drug Administration, and a program launch for non-small cell lung cancer biomarker testing.

Startup Attracts $17M in Funding

Westlake Village startup PureSpectrum this week announced it garnered $17 million in Series B funding from Arthur Ventures, a Minneapolis-based growth equity firm.

Simulations Plus Increases Net Income 49 Percent

Drug modeling software company Simulations Plus Inc. beat analyst estimates for its second fiscal quarter, with net income increasing a whopping 49 percent.

CFO to CEO

Nicholas Lymberopoulos, new chief executive at Providence Cedars-Sinai Tarzana Medical Center, talks about progress on the $644 million Tarzana Reimagined construction project.

Interview with Nick Lymberopoulus, new chief executive of Providence Cedars-Sinai Tarzana Medical Center.

SteadyMD Closes on Second-Round Funding

Westlake Village company lands celebrity investors.

Telehealth company SteadyMD, with local offices in Westlake Village, raises $25 million in Series B round.

Management Update for Arcutis Team

Biopharma adds financial, sales and medical executives.

Late-stage biopharmaceutical company Arcutis Biotherapeutics in late March started bolstering its executive team

INVISIBLE RISKS

Insurance, legal and tech professionals can limit web liability.

Remote work during the pandemic has multiplied cybersecurity problems.

PR Firms Start to Climb Out of Pandemic’s Hole

LIST: With economic opening, marketers prepare for clients eager to share their messages.

PR shops await message glut as they expect business to pick up.

Alpert Barr, Shenon Law to Merge

Encino law firm Alpert Barr & Grant on Wednesday announced a plan to merge with Shenon Law on April 1, taking on three lawyers and two paralegals from the Sherman Oaks firm.

Second Sight Raises Nearly $28 Million as Shares Drop

Second Sight Medical Products on Monday closed its $27.9 million private stock placement, selling 4.7 million shares at $6 each, a move first announced last Wednesday.

SEEDS in Amgen’s Shadow

When big pharma sheds workers, they turn their creativity to new endeavors.

Access to talent is a crucial component of any company, but it counts for even more in the biotech industry.

Building MORE WET Labs

Startups typically seek 70 percent R&D space and 30 percent offices.

Life science companies have particular needs when it comes to office and laboratory space, and developers have started to build inventory in the Conejo Valley.